up and up lansoprazole

Product NDC
11673-117
11-digit product format
116730117
Labeler code
11673
Product ID
11673-117_e84a8913-1d96-445a-8058-e3c8b4a4b391
Type
HUMAN OTC DRUG
Nonproprietary name
Lansoprazole
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Labeler
Target Corporation
Application
ANDA202319
Marketing category
ANDA
Marketing start
2012-05-18
Marketing end
0000-00-00
Substance
LANSOPRAZOLE
Active strength
15 mg/1
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LANSOPRAZOLEACTIVE INGREDIENT0K5C5T2QPGUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
LANSOPRAZOLEACTIVE MOIETY0K5C5T2QPGUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
D&C RED NO. 28INACTIVE INGREDIENT767IP0Y5NHUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
GELATININACTIVE INGREDIENT2G86QN327LUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
MANNITOLINACTIVE INGREDIENT3OWL53L36AUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
MEGLUMINEINACTIVE INGREDIENT6HG8UB2MUYUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
TALCINACTIVE INGREDIENT7SEV7J4R1UUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPUP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11673-117UP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]7Legacy NDC20200401_70bade45-0d35-46db-964e-a8ad9dd91646.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
11673-117-01116730117011 BOTTLE in 1 CARTON (11673-117-01) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE1 bottle2012-05-180000-00-00NoNoCurrent
11673-117-03116730117033 BOTTLE in 1 CARTON (11673-117-03) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE3 bottle2012-05-180000-00-00NoNoCurrent